Role of autophagy and lysosomal drug sequestration in acquired resistance to doxorubicin in MCF-7 cells.
BACKGROUND
The roles and mechanisms involved in starvation-induced autophagy in mammalian cells have been extensively studied. However, less is known about the potential role for autophagy as a survival pathway in acquired drug resistance in cancer cells under nutrient-rich conditions.


METHODS
We selected MCF-7 breast tumor cells for survival in increasing concentrations of doxorubicin and assessed whether the acquisition of doxorubicin resistance was accompanied by changes in doxorubicin and lysosome localization and the activation of autophagy, as assessed by laser scanning confocal microscopy with or without immunohistochemical approaches. The ultrastructure of cells was also viewed using transmission electron microscopy. Cellular levels of autophagy and apoptosis-related proteins were assessed by immunoblotting techniques, while protein turnover was quantified using a flux assay.


RESULTS
As cells acquired resistance to doxorubicin, the subcellular location of the drug moved from the nucleus to the perinuclear region. The location of lysosomes and autophagosomes also changed from being equally distributed throughout the cytoplasm to co-localizing with doxorubicin in the perinuclear region. There was an apparent temporal correlation between the acquisition of doxorubicin resistance and autophagy induction, as measured by increases in monodansylcadaverine staining, LC3-II production, and co-localization of LAMP1 and LC3-II immunofluorescence. Electron microscopy revealed an increase in cytoplasmic vacuoles containing mitochondria and other cellular organelles, also suggestive of autophagy. Consistent with this view, a known autophagy inhibitor (chloroquine) was highly effective in restoring doxorubicin sensitivity in doxorubicin-resistant cells. Moreover, this induction of autophagy correlated temporally with increased expression of the selective cargo receptor p62, which facilitates the delivery of doxorubicin-damaged mitochondria and other organelles to autophagosomes. Finally, we suggest that autophagy associated with doxorubicin resistance may be distinct from classical starvation-induced autophagy, since Beclin 1 and Atg7 expression did not change upon acquisition of doxorubicin resistance, nor did recombinant Bcl2 overexpression or an Atg7 knockdown alter doxorubicin cytotoxicity.


CONCLUSIONS
Taken together, our findings suggest that doxorubicin resistance in MCF-7 breast cancer cells is mediated, at least in part, by the activation of autophagy, which may be distinct from starvation-induced autophagy.
Health Sciences North Research Institute, Sudbury, ON, P3E 5J1, Canada.
Baoqing
B
Guo
Department of Biology, Laurentian University, Sudbury, ON, P3E 2C6, Canada.
Adam
A
Tam
Health Sciences North Research Institute, Sudbury, ON, P3E 5J1, Canada.
Stacey A
SA
Santi
Health Sciences North Research Institute, Sudbury, ON, P3E 5J1, Canada. aparissenti@hsnri.ca.|Department of Biology, Laurentian University, Sudbury, ON, P3E 2C6, Canada. aparissenti@hsnri.ca.|Division of Medical Sciences, Northern Ontario School of Medicine, Sudbury, ON, P3E 2C6, Canada. aparissenti@hsnri.ca.|Faculty of Medicine, Division of Oncology, University of Ottawa, Ottawa, ON, K1H 8M5, Canada. aparissenti@hsnri.ca.
Amadeo M
AM
Parissenti
Autophagy; Breast tumour cells; Doxorubicin; Drug resistance; Drug sequestration; Lysosomes
Cancer Res. 2001 Jan 15;61(2):439-44
11212227
Biochem J. 2003 Feb 15;370(Pt 1):185-93
12435274
Autophagy. 2010 Nov;6(8):1032-41
20818185
Pharmacogenet Genomics. 2009 Jun;19(6):477-88
19440163
Cell. 2005 Jan 28;120(2):237-48
15680329
Hum Mol Genet. 2006 Apr 1;15(7):1209-16
16497721
Autophagy. 2008 Nov;4(8):1083-5
18849663
J Biol Chem. 2007 Aug 17;282(33):24131-45
17580304
Cold Spring Harb Perspect Biol. 2015 Dec 01;7(12 ):null
26626938
Cell Death Differ. 2007 Mar;14 (3):548-58
16946731
Cancer Res. 2005 Apr 15;65(8):2993-5
15833821
Arch Biochem Biophys. 2007 Jun 15;462(2):245-53
17475204
Neurodegener Dis. 2012;10 (1-4):238-41
22204929
Autophagy. 2010 Nov;6(8):1090-106
20890124
Cold Spring Harb Perspect Med. 2016 Apr 01;6(4):a026120
27037419
Cell Death Dis. 2013 Oct 10;4:e838
24113172
Biochim Biophys Acta. 2006 Dec;1763(12):1767-75
17005271
Am J Pathol. 2007 Jan;170(1):75-86
17200184
Toxicol Pathol. 2011 Apr;39(3):516-23
21441228
Trends Biochem Sci. 2011 Jan;36(1):30-8
20728362
Cell Death Differ. 2008 Aug;15(8):1318-29
18421301
Cancer Res. 1993 Sep 15;53(18):4251-6
8395979
PLoS One. 2009 Jul 16;4(7):e6251
19606230
Nature. 2009 Oct 1;461(7264):654-8
19794493
Cell Death Differ. 2011 Apr;18(4):571-80
21311563
Cancer Res. 1989 Aug 15;49(16):4607-14
2545346
Proc Natl Acad Sci U S A. 2005 Jan 4;102(1):192-7
15618392
Autophagy. 2006 Apr-Jun;2(2):85-90
16874083
Cancer Res Treat. 2015 Apr;47(2):313-21
25578058
EMBO J. 2000 Nov 1;19(21):5720-8
11060023
Int J Oncol. 2007 Sep;31(3):473-84
17671672
J Biol Chem. 2000 Jan 14;275(2):992-8
10625637
Int J Biochem Cell Biol. 2004 Dec;36(12):2463-72
15325585
Cell Death Dis. 2012 Jan 26;3:e260
22278287
Nat Rev Mol Cell Biol. 2011 Dec 14;13(1):7-12
22166994
Cancer Res. 1996 Sep 1;56(17):4006-12
8752171
J Cell Biol. 2005 Nov 21;171(4):603-14
16286508
Nat Cell Biol. 2011 Apr;13(4):453-60
21394080
Cell. 2005 Sep 23;122(6):927-39
16179260
Eur J Cell Biol. 1995 Jan;66(1):3-14
7750517
Br J Cancer. 1993 Jun;67(6):1316-23
8099807
J Pharm Sci. 2007 Apr;96(4):729-46
17117426
Cell Struct Funct. 1998 Feb;23(1):33-42
9639028
J Biol Chem. 1991 Sep 15;266(26):17707-12
1832676
Cancer Sci. 2008 Nov;99(11):2200-8
18823378
Biochim Biophys Acta. 2009 Sep;1793(9):1508-15
19289147
Autophagy. 2013 Jul;9(7):1119-20
23670050
Nat Rev Cancer. 2005 Sep;5(9):726-34
16148885
Nature. 2004 Dec 23;432(7020):1032-6
15525940
Int J Cancer. 2016 Jul 1;139(1):23-32
26757106
Am J Cancer Res. 2012;2(2):214-21
22485198
Nat Rev Mol Cell Biol. 2011 Jan;12(1):9-14
21179058
Autophagy. 2011 Sep;7(9):1035-44
21646864
Br J Haematol. 2012 Jul;158(1):108-19
22571717
J Biol Chem. 2007 Apr 27;282(17 ):13123-32
17337444
J Histochem Cytochem. 1993 Oct;41(10):1573-7
7902372
J Clin Invest. 2014 Feb;124(2):617-30
24382354
EMBO J. 2008 Jan 23;27(2):433-46
18200046
BMC Cancer. 2008 Nov 03;8:318
18980695
Oncotarget. 2012 Dec;3(12 ):1600-14
23307622
Blood. 1997 May 15;89(10):3745-54
9160680
Cancer Res. 2000 May 1;60(9):2464-72
10811125
Science. 2004 Nov 5;306(5698):990-5
15528435
Antioxid Redox Signal. 2011 Apr 1;14(7):1315-35
20969478
Stem Cells. 2014 Sep;32(9):2309-23
24809620
J Cell Mol Med. 2009 Sep;13(9B):3644-54
20196784
Autophagy. 2008 May;4(4):487-99
18305408
J Biol Chem. 1998 Apr 17;273(16):9357-60
9545256
Breast Cancer Res Treat. 2003 Nov;82(2):125-41
14692656
Oncogene. 2008 Oct 27;27(50):6434-51
18955971
Semin Cell Dev Biol. 2010 Sep;21(7):683-90
20223289
Anticancer Drug Des. 2000 Jun;15(3):183-90
11049086
J Biol Chem. 2006 Feb 10;281(6):3017-24
16303767
Biochem Pharmacol. 2012 Mar 15;83(6):747-57
22226932
Autophagy. 2014 Aug;10(8):1391-402
24991838
Biochem Pharmacol. 2010 Feb 1;79(3):339-49
19737541
Cancer Res. 2007 Mar 1;67(5):2217-25
17332352
Science. 2004 Nov 5;306(5698):1037-40
15528445
Nat Rev Mol Cell Biol. 2007 Sep;8(9):741-52
17717517
Dev Cell. 2004 Apr;6(4):463-77
15068787
Autophagy. 2007 Mar-Apr;3(2):160-2
17204854